Patents by Inventor Peter Stopfer

Peter Stopfer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical dosage form for immediate release of an indolinone derivative
    Patent number: 10105323
    Abstract: The present invention relates to a pharmaceutical dosage form delivering an immediate release profile containing the active substance 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate.
    Type: Grant
    Filed: May 9, 2017
    Date of Patent: October 23, 2018
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Roman Messerschmid, Peter Lach, Torsten Sokoliess, Peter Stopfer, Dirk Trommeshauser
  • PHARMACEUTICAL DOSAGE FORM FOR IMMEDIATE RELEASE OF AN INDOLINONE DERIVATIVE
    Publication number: 20170239191
    Abstract: The present invention relates to a pharmaceutical dosage form delivering an immediate release profile containing the active substance 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate.
    Type: Application
    Filed: May 9, 2017
    Publication date: August 24, 2017
    Inventors: Roman MESSERSCHMID, Peter LACH, Torsten SOKOLIESS, Peter STOPFER, Dirk TROMMESHAUSER
  • Pharmaceutical dosage form for immediate release of an indolinone derivative
    Publication number: 20170065529
    Abstract: The present invention relates to a pharmaceutical dosage form delivering an immediate release profile containing the active substance 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate.
    Type: Application
    Filed: September 9, 2015
    Publication date: March 9, 2017
    Inventors: Roman MESSERSCHMID, Peter LACH, Thorsten SOKOLIESS, Peter STOPFER, Dirk TROMMESHAUSER
  • METHODS OF ADMINISTERING AN EGFR INHIBITOR
    Publication number: 20160287591
    Abstract: Disclosed are methods of treating a patient having cancer with an EGFR inhibitor requiring an active step of avoiding or modifying the co-administration of such drugs with P-gp modulators. This invention also relates to a medicament for treating a patient having cancer, comprising an EGFR inhibitor as the active product ingredient, customized for avoiding co-administration with P-gp inducers and/or inhibitors by an instruction added to the medicament or the package containing said medicament.
    Type: Application
    Filed: June 9, 2016
    Publication date: October 6, 2016
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Robert Michael LORENCE, Mehdi SHAHIDI, Peter STOPFER
  • Pharmaceutical dosage form for immediate release of an indolinone derivative
    Publication number: 20140163040
    Abstract: The present invention relates to a pharmaceutical dosage form delivering an immediate release profile containing the active substance 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate.
    Type: Application
    Filed: February 10, 2014
    Publication date: June 12, 2014
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Roman MESSERSCHMID, Peter LACH, Thorsten SOKOLIESS, Peter STOPFER, Dirk TROMMESHAUSER
  • METHODS OF ADMINISTERING AN EGFR INHIBITOR
    Publication number: 20130289056
    Abstract: Disclosed are methods of treating a patient having cancer with an EGFR inhibitor requiring an active step of avoiding or modifying the co-administration of such drugs with P-gp modulators. This invention also relates to a medicament for treating a patient having cancer, comprising an EGFR inhibitor as the active product ingredient, customized for avoiding co-administration with P-gp inducers and/or inhibitors by an instruction added to the medicament or the package containing said medicament.
    Type: Application
    Filed: August 24, 2011
    Publication date: October 31, 2013
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Robert Michael Lorence, Mehdi Shahidi, Peter Stopfer
  • Pharmaceutical dosage form for immediate release of an indolinone derivative
    Publication number: 20130203773
    Abstract: The present invention relates to a pharmaceutical dosage form delivering an immediate release profile containing the active substance 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate.
    Type: Application
    Filed: March 8, 2013
    Publication date: August 8, 2013
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Roman MESSERSCHMID, Peter LACH, Thorsten SOKOLIESS, Peter STOPFER, Dirk TROMMESHAUSER
  • Pharmaceutical dosage form for immediate release of an indolinone derivative
    Publication number: 20110190318
    Abstract: The present invention relates to a pharmaceutical dosage form delivering an immediate release profile containing the active substance 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate.
    Type: Application
    Filed: June 4, 2009
    Publication date: August 4, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Roman Messerschmid, Peter Lach, Torsten Sokoliess, Peter Stopfer, Dirk Trommeshauser